Yuling Qiu

3.3k total citations · 1 hit paper
89 papers, 2.4k citations indexed

About

Yuling Qiu is a scholar working on Molecular Biology, Pharmacology and Cancer Research. According to data from OpenAlex, Yuling Qiu has authored 89 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Biology, 17 papers in Pharmacology and 13 papers in Cancer Research. Recurrent topics in Yuling Qiu's work include PI3K/AKT/mTOR signaling in cancer (9 papers), Hemoglobinopathies and Related Disorders (8 papers) and Venomous Animal Envenomation and Studies (8 papers). Yuling Qiu is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (9 papers), Hemoglobinopathies and Related Disorders (8 papers) and Venomous Animal Envenomation and Studies (8 papers). Yuling Qiu collaborates with scholars based in China, South Korea and United States. Yuling Qiu's co-authors include Dexin Kong, Meihua Jin, Ran Wang, Kailong Wang, Haiyang Yu, Shuangshuang Yin, Xulei Tang, Roberto Bolli, Tao Wang and Yiman Liu and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Scientific Reports.

In The Last Decade

Yuling Qiu

84 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anticancer activities of TCM and their active components against tumor metastasis

2020 257 citations Kailong Wang, Yingying Shao et al. Biomedicine & Pharmacotherapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yuling Qiu China	26	1.3k	415	399	320	297	89	2.4k
James O’Kelly United States	30	1.4k 1.1×	492 1.2×	243 0.6×	254 0.8×	477 1.6×	59	3.0k
Chi Hin Cho China	28	1.2k 1.0×	225 0.5×	486 1.2×	138 0.4×	593 2.0×	54	2.4k
Jie Su China	26	1.1k 0.9×	148 0.4×	246 0.6×	194 0.6×	292 1.0×	133	2.1k
Lea‐Yea Chuang Taiwan	30	1.2k 1.0×	197 0.5×	239 0.6×	202 0.6×	408 1.4×	106	2.6k
Won‐Ki Baek South Korea	28	1.1k 0.8×	250 0.6×	314 0.8×	231 0.7×	313 1.1×	88	2.3k
Chang Han United States	28	1.2k 0.9×	148 0.4×	519 1.3×	434 1.4×	469 1.6×	61	2.5k
Deliang Cao United States	36	2.4k 1.9×	320 0.8×	1.0k 2.6×	306 1.0×	580 2.0×	82	4.0k
Tao Li China	30	1.3k 1.0×	139 0.3×	427 1.1×	224 0.7×	315 1.1×	149	2.4k
Maqbool Ahmed Saudi Arabia	34	1.5k 1.2×	376 0.9×	474 1.2×	198 0.6×	607 2.0×	81	2.8k

Countries citing papers authored by Yuling Qiu

Since Specialization

Citations

This map shows the geographic impact of Yuling Qiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuling Qiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuling Qiu more than expected).

Fields of papers citing papers by Yuling Qiu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuling Qiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuling Qiu. The network helps show where Yuling Qiu may publish in the future.

Co-authorship network of co-authors of Yuling Qiu

This figure shows the co-authorship network connecting the top 25 collaborators of Yuling Qiu. A scholar is included among the top collaborators of Yuling Qiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuling Qiu. Yuling Qiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ling, Xiaoting, et al.. (2025). Ultrasensitive Single-Molecule Immunoassays Built on Digital Techniques for Low Amounts of Biomarker Detection. ACS Sensors. 10(8). 5380–5409. 1 indexed citations

Feng, Jing, Xueshan Li, Dingding Fan, et al.. (2025). Harnessing CO2 fixation and reducing power recycling for enhanced polyhydroxyalkanoates industrial bioproduction. Metabolic Engineering. 91. 204–216. 4 indexed citations

Yin, Shuangshuang, et al.. (2025). Ferroptosis and pyroptosis are connected through autophagy: a new perspective of overcoming drug resistance. Molecular Cancer. 24(1). 23–23. 16 indexed citations

Zhou, Yingling, Ying Chen, Juanjuan Dai, et al.. (2025). An injectable gambogic acid loaded nanocomposite hydrogel enhances antitumor effect by reshaping immunosuppressive tumor microenvironment. Materials Today Bio. 31. 101611–101611. 5 indexed citations

Zhang, Tiantian, Huimin Li, Shuangshuang Yin, et al.. (2025). Ubiquitination‐Dependent LLGL2 Degradation Drives Colorectal Cancer Progression via THBS3 mRNA Stabilization. Advanced Science. 12(39). e01656–e01656.

Qiu, Yuling, Dingding Fan, Jianxin Wang, et al.. (2025). High throughput construction of species characterized bacterial biobank for functional bacteria screening: demonstration with GABA-producing bacteria. Frontiers in Microbiology. 16. 1545877–1545877. 2 indexed citations

Yin, Shuangshuang, Miaomiao Jiang, Lifeng Han, et al.. (2025). Suppression of LIF in tumor-associated macrophages contributing to the PD-1/PD-L1 blockade in hepatocellular carcinoma. Journal of Pharmaceutical Analysis. 15(10). 101286–101286.

Liu, Yiman, Lu Chen, Jinghui Wang, et al.. (2024). Repurposing cyclovirobuxine D as a novel inhibitor of colorectal cancer progression via modulating the CCT3/YAP axis. British Journal of Pharmacology. 181(21). 4348–4368. 3 indexed citations

Shao, Yingying, et al.. (2024). Immunometabolism in cancer: basic mechanisms and new targeting strategy. Cell Death Discovery. 10(1). 236–236. 15 indexed citations

10.

Zhou, Shiyue, et al.. (2023). The role of myeloid-derived suppressor cells in liver cancer. Discover Oncology. 14(1). 77–77. 17 indexed citations

11.

Lu, Jia, Xuejiao Bai, Minru Liao, et al.. (2023). Targeting cholesterol metabolism in Cancer: From molecular mechanisms to therapeutic implications. Biochemical Pharmacology. 218. 115907–115907. 24 indexed citations

12.

Zhang, Yan, Tingting Guo, Shurong Li, et al.. (2023). Anticancer efficacy of hirsuteine against colorectal cancer by opposite modulation of wild-type and mutant p53. Discover Oncology. 14(1). 84–84. 2 indexed citations

13.

Yan, Jie, et al.. (2021). The β‐chain mutation p.Trp433Stop impairs fibrinogen secretion: A novel nonsense mutation associated with hypofibrinogenemia. International Journal of Laboratory Hematology. 43(6). 1549–1556. 3 indexed citations

14.

Zhang, Ning, Yingying Huang, Xiaolin Peng, et al.. (2021). Lansoprazole Alone or in Combination With Gefitinib Shows Antitumor Activity Against Non-small Cell Lung Cancer A549 Cells in vitro and in vivo. Frontiers in Cell and Developmental Biology. 9. 655559–655559. 13 indexed citations

15.

Wang, Rui, Hongwei Liu, Yingying Shao, et al.. (2019). Sophoridine Inhibits Human Colorectal Cancer Progression via Targeting MAPKAPK2. Molecular Cancer Research. 17(12). 2469–2479. 31 indexed citations

16.

Yang, Shenshen, Kailong Wang, Xiaomei Bao, et al.. (2019). Alkaloids from Traditional Chinese Medicine against hepatocellular carcinoma. Biomedicine & Pharmacotherapy. 120. 109543–109543. 131 indexed citations

17.

Ji, Ning, Chen Shao, Yu‐Fen Chen, et al.. (2018). Spinacetin Suppresses the Mast Cell Activation and Passive Cutaneous Anaphylaxis in Mouse Model. Frontiers in Pharmacology. 9. 824–824. 18 indexed citations

18.

Peng, Xiaolin, Yao Liu, Xin Peng, et al.. (2018). Clinical features and the molecular biomarkers of olfactory neuroblastoma. Pathology - Research and Practice. 214(8). 1123–1129. 13 indexed citations

19.

Yu, Haiyang, Yuling Qiu, Xu Pang, et al.. (2017). Lycorine Promotes Autophagy and Apoptosis via TCRP1/Akt/mTOR Axis Inactivation in Human Hepatocellular Carcinoma. Molecular Cancer Therapeutics. 16(12). 2711–2723. 72 indexed citations

20.

Qiu, Yuling, Young Moo Choo, Hyung Joo Yoon, et al.. (2011). Fibrin(ogen)olytic activity of bumblebee venom serine protease. Toxicology and Applied Pharmacology. 255(2). 207–213. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact